Follow-up study for a heart device in heart failure patients
Part of Heart & circulation clinical trials.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign written informed consent, and you are 18 or older
- You have ongoing heart failure symptoms that are at least moderate (NYHA class 2 or higher)
- You have higher pressure on the left side of the heart than the right side (a pressure difference of at least 5 mmHg on testing)
- Your heart pumping strength is low enough to fit the study (LVEF at least 15%); if your pumping is fairly preserved, specific blood marker levels must be elevated
- Your heart failure medicines have been stable for at least 1 month before joining
- You do NOT have several serious conditions (like very advanced heart failure, major right-heart failure, certain valve disease, recent serious clots/bleeding, or major lung disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that creates a small shunt (passage) in the heart to help relieve pressure and improve symptoms in people with heart failure and a weak heart pump. The goal is to see if the device is safe and helpful for patients like you.
This study tests a new way to place a heart device lead to help the heart beat in sync for people with heart failure and a specific abnormal heart rhythm. The goal is to see if this method improves outcomes compared with standard treatment.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
This study looks at how well the Occlutech AFR device works for people with a failing Fontan circulation. It is only open to those who already received the device through a special early-access program.
This trial provides access to a device called the Atrial Flow Regulator, which helps manage heart conditions by regulating blood flow. It may be an option for patients who have limited alternatives.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.